Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

The Potential of Hydrogen for Improving Mental Disorders

Author(s): Yasushi Satoh*

Volume 27, Issue 5, 2021

Published on: 13 November, 2020

Page: [695 - 702] Pages: 8

DOI: 10.2174/1381612826666201113095938

Price: $65

Abstract

In 2007, Ohsawa and colleagues reported that molecular hydrogen (H2) gas significantly reduced the infarct volume size in a rat model of cerebral infarction, which was, at least, partially due to scavenging hydroxyl radicals. Since then, multiple studies have shown that H2 has not only anti-oxidative but also anti-inflammatory and anti-apoptotic properties, which has ignited interest in the clinical use of H2 in diverse diseases. A growing body of studies has indicated that H2 affects both mental and physical conditions. Mental disorders are characterized by disordered mood, thoughts, and behaviors that affect the ability to function in daily life. However, there is no sure way to prevent mental disorders. Although antidepressant and antianxiety drugs relieve symptoms of depression and anxiety, they have efficacy limitations and are accompanied by a wide range of side effects. While mental disorders are generally thought to be caused by a variety of genetic and/or environmental factors, recent progress has shown that these disorders are strongly associated with increased oxidative and inflammatory stress. Thus, H2 has received much attention as a novel therapy for the prevention and treatment of mental disorders. This review summarizes the recent progress in the use of H2 for the treatment of mental disorders and other related diseases. We also discuss the potential mechanisms of the biomedical effects of H2 and conclude that H2 could offer relief to people suffering from mental disorders.

Keywords: Molecular hydrogen, mental disorder, depression, neuroinflammation, oxidative stress, depression-like behavior.

« Previous Next »
[1]
Stein DJ. What is a mental disorder? A perspective from cognitive-affective science. Can J Psychiatry 2013; 58(12): 656-62.
[http://dx.doi.org/10.1177/070674371305801202] [PMID: 24331284]
[2]
Bertolote JM, Fleischmann A. Suicide and psychiatric diagnosis: a worldwide perspective. World Psychiatry 2002; 1(3): 181-5.
[PMID: 16946849]
[3]
Leckman JF, Bloch MH, King RA, Scahill L. Phenomenology of tics and natural history of tic disorders. Adv Neurol 2006; 99: 1-16.
[PMID: 16536348]
[4]
Ormel J, Petukhova M, Chatterji S, et al. Disability and treatment of specific mental and physical disorders across the world. Br J Psychiatry 2008; 192(5): 368-75.
[http://dx.doi.org/10.1192/bjp.bp.107.039107] [PMID: 18450663]
[5]
Satoh Y, Endo S, Ikeda T, et al. Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory. J Neurosci 2007; 27(40): 10765-76.
[http://dx.doi.org/10.1523/JNEUROSCI.0117-07.2007] [PMID: 17913910]
[6]
Stahl SM, Lonnen AJ. The mechanism of Drug-induced Akathsia. CNS Spectr 2011; Stahl.
[PMID: 21406165]
[7]
Lane RM. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol 1998; 12(2): 192-214.
[http://dx.doi.org/10.1177/026988119801200212] [PMID: 9694033]
[8]
Koliscak LP, Makela EH. Selective serotonin reuptake inhibitor-induced akathisia. J Am Pharm Assoc (2003) 2009; 49(2): e28-36.
[http://dx.doi.org/10.1331/JAPhA.2009.08083] [PMID: 19289334]
[9]
Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996; 57(10): 449-54.
[http://dx.doi.org/10.4088/JCP.v57n1002] [PMID: 8909330]
[10]
Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol 2008; 101(10A): 14D-9D.
[http://dx.doi.org/10.1016/j.amjcard.2008.02.003] [PMID: 18474268]
[11]
Torgersen S, Lygren S, Oien PA, et al. A twin study of personality disorders. Compr Psychiatry 2000; 41(6): 416-25.
[http://dx.doi.org/10.1053/comp.2000.16560] [PMID: 11086146]
[12]
Reichborn-Kjennerud T. The genetic epidemiology of personality disorders. Dialogues Clin Neurosci 2010; 12(1): 103-14.
[PMID: 20373672]
[13]
Miklowitz DJ, Chang KD. Prevention of bipolar disorder in at-risk children: theoretical assumptions and empirical foundations. Dev Psychopathol 2008; 20(3): 881-97.
[http://dx.doi.org/10.1017/S0954579408000424] [PMID: 18606036]
[14]
Krabbendam L, van Os J. Schizophrenia and urbanicity: a major environmental influence--conditional on genetic risk. Schizophr Bull 2005; 31(4): 795-9.
[http://dx.doi.org/10.1093/schbul/sbi060] [PMID: 16150958]
[15]
Stiller AL, Drugan RC, Hazi A, Kent SP. Stress resilience and vulnerability: the association with rearing conditions, endocrine function, immunology, and anxious behavior. Psychoneuroendocrinology 2011; 36(9): 1383-95.
[http://dx.doi.org/10.1016/j.psyneuen.2011.03.012] [PMID: 21530089]
[16]
Van den Hove DL, Kenis G, Brass A, et al. Vulnerability versus resilience to prenatal stress in male and female rats; implications from gene expression profiles in the hippocampus and frontal cortex. Eur Neuropsychopharmacol 2013; 23(10): 1226-46.
[http://dx.doi.org/10.1016/j.euroneuro.2012.09.011] [PMID: 23199416]
[17]
Gao Q, Song H, Wang XT, et al. Molecular hydrogen increases resilience to stress in mice. Sci Rep 2017; 7(1): 9625.
[http://dx.doi.org/10.1038/s41598-017-10362-6] [PMID: 28852144]
[18]
Kennedy C, Sokoloff L. An adaptation of the nitrous oxide method to the study of the cerebral circulation in children; normal values for cerebral blood flow and cerebral metabolic rate in childhood. J Clin Invest 1957; 36(7): 1130-7.
[http://dx.doi.org/10.1172/JCI103509] [PMID: 13449166]
[19]
Ghanizadeh A, Berk M. Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia. Med Gas Res 2013; 3(1): 11.
[http://dx.doi.org/10.1186/2045-9912-3-11] [PMID: 23742229]
[20]
Starke RM, Chalouhi N, Ali MS, et al. The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res 2013; 10(3): 247-55.
[http://dx.doi.org/10.2174/15672026113109990003] [PMID: 23713738]
[21]
Berg D, Youdim MB, Riederer P. Redox imbalance. Cell Tissue Res 2004; 318(1): 201-13.
[http://dx.doi.org/10.1007/s00441-004-0976-5] [PMID: 15365815]
[22]
Kohen R, Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002; 30(6): 620-50.
[http://dx.doi.org/10.1080/01926230290166724] [PMID: 12512863]
[23]
Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35(3): 676-92.
[http://dx.doi.org/10.1016/j.pnpbp.2010.05.004] [PMID: 20471444]
[24]
Raffa M, Barhoumi S, Atig F, Fendri C, Kerkeni A, Mechri A. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39(2): 371-5.
[http://dx.doi.org/10.1016/j.pnpbp.2012.07.013] [PMID: 22841966]
[25]
Ranjekar PK, Hinge A, Hegde MV, et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 2003; 121(2): 109-22.
[http://dx.doi.org/10.1016/S0165-1781(03)00220-8] [PMID: 14656446]
[26]
Andreazza AC, Wang JF, Salmasi F, Shao L, Young LT. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem 2013; 127(4): 552-61.
[http://dx.doi.org/10.1111/jnc.12316] [PMID: 23692477]
[27]
Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 2016; 21(12): 1696-709.
[http://dx.doi.org/10.1038/mp.2016.3] [PMID: 26903267]
[28]
Bai YM, Chiou WF, Su TP, Li CT, Chen MH. Pro-inflammatory cytokine associated with somatic and pain symptoms in depression. J Affect Disord 2014; 155: 28-34.
[http://dx.doi.org/10.1016/j.jad.2013.10.019] [PMID: 24176538]
[29]
Lotrich FE. Inflammatory cytokine-associated depression. Brain Res 2015; 1617: 113-25.
[http://dx.doi.org/10.1016/j.brainres.2014.06.032] [PMID: 25003554]
[30]
Udina M, Moreno-España J, Capuron L, et al. Cytokine-induced depression: current status and novel targets for depression therapy. CNS Neurol Disord Drug Targets 2014; 13(6): 1066-74.
[http://dx.doi.org/10.2174/1871527313666140612121921] [PMID: 24923336]
[31]
Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008; 358(1): 55-68.
[http://dx.doi.org/10.1056/NEJMra073096] [PMID: 18172175]
[32]
Loftis JM, Huckans M, Morasco BJ. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 2010; 37(3): 519-33.
[http://dx.doi.org/10.1016/j.nbd.2009.11.015] [PMID: 19944762]
[33]
Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 2014; 71(10): 1121-8.
[http://dx.doi.org/10.1001/jamapsychiatry.2014.1332] [PMID: 25133871]
[34]
Kim YK, Na KS, Myint AM, Leonard BE. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2016; 64: 277-84.
[http://dx.doi.org/10.1016/j.pnpbp.2015.06.008] [PMID: 26111720]
[35]
Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012; 37(1): 137-62.
[http://dx.doi.org/10.1038/npp.2011.205] [PMID: 21918508]
[36]
Du YJ, Yang CJ, Li B, et al. Association of pro-inflammatory cytokines, cortisol and depression in patients with chronic obstructive pulmonary disease. Psychoneuroendocrinology 2014; 46: 141-52.
[http://dx.doi.org/10.1016/j.psyneuen.2014.04.020] [PMID: 24882166]
[37]
Al-Maskari M, Al-Shukaili A, Al-Mammari A. Pro-inflammatory cytokines in Omani type 2 diabetic patients presenting anxiety and depression. Iran J Immunol 2010; 7(2): 124-9.
[PMID: 20574126]
[38]
Köhler O, Benros ME, Nordentoft M, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 2014; 71(12): 1381-91.
[http://dx.doi.org/10.1001/jamapsychiatry.2014.1611] [PMID: 25322082]
[39]
Rostom A, Dube C, Wells G, et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 2002; (4): CD002296.
[PMID: 12519573]
[40]
Gałecki P, Mossakowska-Wójcik J, Talarowska M. The anti-inflammatory mechanism of antidepressants - SSRIs, SNRIs. Prog Neuropsychopharmacol Biol Psychiatry 2018; 80(Pt C): 291-4.
[http://dx.doi.org/10.1016/j.pnpbp.2017.03.016] [PMID: 28342944]
[41]
Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D. Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation 2013; 10: 142.
[http://dx.doi.org/10.1186/1742-2094-10-142] [PMID: 24289502]
[42]
Bakunina N, Pariante CM, Zunszain PA. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology 2015; 144(3): 365-73.
[http://dx.doi.org/10.1111/imm.12443] [PMID: 25580634]
[43]
Scapagnini G, Davinelli S, Drago F, De Lorenzo A, Oriani G. Antioxidants as antidepressants: fact or fiction? CNS Drugs 2012; 26(6): 477-90.
[http://dx.doi.org/10.2165/11633190-000000000-00000] [PMID: 22668245]
[44]
Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008; 11(6): 851-76.
[http://dx.doi.org/10.1017/S1461145707008401] [PMID: 18205981]
[45]
Anderson G, Berk M, Dodd S, et al. Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2013; 42: 1-4.
[http://dx.doi.org/10.1016/j.pnpbp.2012.10.008] [PMID: 23085074]
[46]
Salim S, Chugh G, Asghar M. Inflammation in anxiety. Adv Protein Chem Struct Biol 2012; 88: 1-25.
[http://dx.doi.org/10.1016/B978-0-12-398314-5.00001-5] [PMID: 22814704]
[47]
Falcone T, Carlton E, Lee C, et al. Does systemic inflammation play a role in pediatric psychosis? Clin Schizophr Relat Psychoses 2015; 9(2): 65-78B.
[http://dx.doi.org/10.3371/CSRP.FACA.030813] [PMID: 23491967]
[48]
Lopresti AL, Maker GL, Hood SD, Drummond PD. A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog Neuropsychopharmacol Biol Psychiatry 2014; 48: 102-11.
[http://dx.doi.org/10.1016/j.pnpbp.2013.09.017] [PMID: 24104186]
[49]
Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 2012; 20(3): 127-50.
[http://dx.doi.org/10.1007/s10787-011-0111-7] [PMID: 22271002]
[50]
Russo SJ, Murrough JW, Han MH, Charney DS, Nestler EJ. Neurobiology of resilience. Nat Neurosci 2012; 15(11): 1475-84.
[http://dx.doi.org/10.1038/nn.3234] [PMID: 23064380]
[51]
Franklin TB, Saab BJ, Mansuy IM. Neural mechanisms of stress resilience and vulnerability. Neuron 2012; 75(5): 747-61.
[http://dx.doi.org/10.1016/j.neuron.2012.08.016] [PMID: 22958817]
[52]
Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinol Lett 2008; 29(3): 287-91.
[PMID: 18580840]
[53]
Hanaoka T, Kamimura N, Yokota T, Takai S, Ohta S. Molecular hydrogen protects chondrocytes from oxidative stress and indirectly alters gene expressions through reducing peroxynitrite derived from nitric oxide. Med Gas Res 2011; 1(1): 18.
[http://dx.doi.org/10.1186/2045-9912-1-18] [PMID: 22146365]
[54]
Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007; 13(6): 688-94.
[http://dx.doi.org/10.1038/nm1577] [PMID: 17486089]
[55]
Zhang XY, Tan YL, Cao LY, et al. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res 2006; 81(2-3): 291-300.
[http://dx.doi.org/10.1016/j.schres.2005.10.011] [PMID: 16309894]
[56]
Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N. Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr 2010; 46(2): 140-9.
[http://dx.doi.org/10.3164/jcbn.09-100] [PMID: 20216947]
[57]
Shalev H, Serlin Y, Friedman A. Breaching the blood-brain barrier as a gate to psychiatric disorder. Cardiovasc Psychiatry Neurol 2009; 2009: 278531.
[http://dx.doi.org/10.1155/2009/278531] [PMID: 19936105]
[58]
Fleminger S. Long-term psychiatric disorders after traumatic brain injury. Eur J Anaesthesiol Suppl 2008; 42: 123-30.
[http://dx.doi.org/10.1017/S0265021507003250] [PMID: 18289429]
[59]
Guerreiro DF, Navarro R, Silva M, Carvalho M, Gois C. Psychosis secondary to traumatic brain injury. Brain Inj 2009; 23(4): 358-61.
[http://dx.doi.org/10.1080/02699050902800918] [PMID: 19274520]
[60]
Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun 2017; 60: 1-12.
[http://dx.doi.org/10.1016/j.bbi.2016.03.010] [PMID: 26995317]
[61]
Tian R, Hou Z, Hao S, et al. Hydrogen-rich water attenuates brain damage and inflammation after traumatic brain injury in rats. Brain Res 2016; 1637: 1-13.
[http://dx.doi.org/10.1016/j.brainres.2016.01.029] [PMID: 26826009]
[62]
Ohta S. Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications. Curr Pharm Des 2011; 17(22): 2241-52.
[http://dx.doi.org/10.2174/138161211797052664] [PMID: 21736547]
[63]
Dinan TG, Cryan JF. Brain-gut-Microbiota Axis and Mental Health. Psychosom Med 2017; 79(8): 920-6.
[http://dx.doi.org/10.1097/PSY.0000000000000519] [PMID: 28806201]
[64]
Malan-Muller S, Valles-Colomer M, Raes J, Lowry CA, Seedat S, Hemmings SMJ. The gut microbiome and mental health: implications for anxiety- and trauma-related disorders. OMICS 2018; 22(2): 90-107.
[http://dx.doi.org/10.1089/omi.2017.0077] [PMID: 28767318]
[65]
Bruce-Keller AJ, Salbaum JM, Berthoud HR. Harnessing gut Microbes for Mental Health: Getting From Here to There. Biol Psychiatry 2018; 83(3): 214-23.
[http://dx.doi.org/10.1016/j.biopsych.2017.08.014] [PMID: 29031410]
[66]
Pennisi E. Gut bacteria linked to mental well-being and depression. Science 2019; 363(6427): 569.
[http://dx.doi.org/10.1126/science.363.6427.569] [PMID: 30733395]
[67]
Cryan JF, O’Riordan KJ, Cowan CSM, et al. The microbiota-Gut-Brain Axis. Physiol Rev 2019; 99(4): 1877-2013.
[http://dx.doi.org/10.1152/physrev.00018.2018] [PMID: 31460832]
[68]
Wang HX, Wang YP. Gut Microbiota-brain Axis. Chin Med J (Engl) 2016; 129(19): 2373-80.
[http://dx.doi.org/10.4103/0366-6999.190667] [PMID: 27647198]
[69]
Thauer RK, Jungermann K, Decker K. Energy conservation in chemotrophic anaerobic bacteria. Bacteriol Rev 1977; 41(1): 100-80.
[http://dx.doi.org/10.1128/MMBR.41.1.100-180.1977] [PMID: 860983]
[70]
Christl SU, Murgatroyd PR, Gibson GR, Cummings JH. Production, metabolism, and excretion of hydrogen in the large intestine. Gastroenterology 1992; 102(4 Pt 1): 1269-77.
[http://dx.doi.org/10.1016/0016-5085(92)90765-Q] [PMID: 1551534]
[71]
Strocchi A, Levitt MD. Maintaining intestinal H2 balance: credit the colonic bacteria. Gastroenterology 1992; 102(4 Pt 1): 1424-6.
[http://dx.doi.org/10.1016/0016-5085(92)90790-6] [PMID: 1551553]
[72]
Kajiya M, Sato K, Silva MJ, et al. Hydrogen from intestinal bacteria is protective for Concanavalin A-induced hepatitis. Biochem Biophys Res Commun 2009; 386(2): 316-21.
[http://dx.doi.org/10.1016/j.bbrc.2009.06.024] [PMID: 19523450]
[73]
Suzuki A, Ito M, Hamaguchi T, et al. Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson’s disease. PLoS One 2018; 13(12): e0208313.
[http://dx.doi.org/10.1371/journal.pone.0208313] [PMID: 30586410]
[74]
Maier RJ, Olson J, Olczak A. Hydrogen-oxidizing capabilities of Helicobacter hepaticus and in vivo availability of the substrate. J Bacteriol 2003; 185(8): 2680-2.
[http://dx.doi.org/10.1128/JB.185.8.2680-2682.2003] [PMID: 12670994]
[75]
Cramer T, Kisliouk T, Yeshurun S, Meiri N. The balance between stress resilience and vulnerability is regulated by corticotropin-releasing hormone during the critical postnatal period for sensory development. Dev Neurobiol 2015; 75(8): 842-53.
[http://dx.doi.org/10.1002/dneu.22252] [PMID: 25447645]
[76]
Gillespie CF, Phifer J, Bradley B, Ressler KJ. Risk and resilience: genetic and environmental influences on development of the stress response. Depress Anxiety 2009; 26(11): 984-92.
[http://dx.doi.org/10.1002/da.20605] [PMID: 19750552]
[77]
DeMorrow S. Role of the hypothalamic-pituitary-adrenal axis in health and disease. Int J Mol Sci 2018; 19(4): 19.
[http://dx.doi.org/10.3390/ijms19040986] [PMID: 29587417]
[78]
Wen D, Zhao P, Hui R, et al. Hydrogen-rich saline attenuates anxiety-like behaviors in morphine-withdrawn mice. Neuropharmacology 2017; 118: 199-208.
[http://dx.doi.org/10.1016/j.neuropharm.2017.03.029] [PMID: 28359771]
[79]
Zhang Y, Su WJ, Chen Y, et al. Effects of hydrogen-rich water on depressive-like behavior in mice. Sci Rep 2016; 6: 23742.
[http://dx.doi.org/10.1038/srep23742] [PMID: 27026206]
[80]
Satoh Y, Araki Y, Kashitani M, et al. Molecular hydrogen prevents social deficits and depression-like behaviors induced by low-intensity blast in mice. J Neuropathol Exp Neurol 2018; 77(9): 827-36.
[http://dx.doi.org/10.1093/jnen/nly060] [PMID: 30053086]
[81]
Terrio H, Brenner LA, Ivins BJ, et al. Traumatic brain injury screening: preliminary findings in a US Army Brigade Combat Team. J Head Trauma Rehabil 2009; 24(1): 14-23.
[http://dx.doi.org/10.1097/HTR.0b013e31819581d8] [PMID: 19158592]
[82]
Polusny MA, Ries BJ, Meis LA, et al. Effects of parents’ experiential avoidance and PTSD on adolescent disaster-related posttraumatic stress symptomatology. J Fam Psychol 2011; 25(2): 220-9.
[http://dx.doi.org/10.1037/a0022945] [PMID: 21480702]
[83]
Lindquist LK, Love HC, Elbogen EB. Traumatic Brain Injury in Iraq and Afghanistan veterans: new results from a national random sample study. J Neuropsychiatry Clin Neurosci 2017; 29(3): 254-9.
[http://dx.doi.org/10.1176/appi.neuropsych.16050100] [PMID: 28121256]
[84]
Shetty AK, Mishra V, Kodali M, Hattiangady B. Blood brain barrier dysfunction and delayed neurological deficits in mild traumatic brain injury induced by blast shock waves. Front Cell Neurosci 2014; 8: 232.
[PMID: 25165433]
[85]
Cho HJ, Sajja VS, Vandevord PJ, Lee YW. Blast induces oxidative stress, inflammation, neuronal loss and subsequent short-term memory impairment in rats. Neuroscience 2013; 253: 9-20.
[http://dx.doi.org/10.1016/j.neuroscience.2013.08.037] [PMID: 23999126]
[86]
Kabu S, Jaffer H, Petro M, et al. Blast-associated shock waves result in increased brain vascular leakage and elevated ros levels in a rat model of traumatic brain injury. PLoS One 2015; 10(5): e0127971.
[http://dx.doi.org/10.1371/journal.pone.0127971] [PMID: 26024446]
[87]
Guo Q, Yin X, Qiao M, et al. Hydrogen-rich water ameliorates autistic-like behavioral abnormalities in valproic acid-treated adolescent mice offspring. Front Behav Neurosci 2018; 12: 170.
[http://dx.doi.org/10.3389/fnbeh.2018.00170] [PMID: 30127728]
[88]
Yonamine R, Satoh Y, Kodama M, Araki Y, Kazama T. Coadministration of hydrogen gas as part of the carrier gas mixture suppresses neuronal apoptosis and subsequent behavioral deficits caused by neonatal exposure to sevoflurane in mice. Anesthesiology 2013; 118(1): 105-13.
[http://dx.doi.org/10.1097/ALN.0b013e318275146d] [PMID: 23221861]
[89]
Satomoto M, Satoh Y, Terui K, et al. Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology 2009; 110(3): 628-37.
[http://dx.doi.org/10.1097/ALN.0b013e3181974fa2] [PMID: 19212262]
[90]
Mizuno K, Sasaki AT, Ebisu K, et al. Hydrogen-rich water for improvements of mood, anxiety, and autonomic nerve function in daily life. Med Gas Res 2018; 7(4): 247-55.
[PMID: 29497485]
[91]
Rosen C, Marvin R, Reilly JL, et al. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis. Clin Schizophr Relat Psychoses 2012; 6(3): 145-51.
[http://dx.doi.org/10.3371/CSRP.6.3.6] [PMID: 23006239]
[92]
Seow LSE, Chua BY, Xie H, et al. Correct recognition and continuum belief of mental disorders in a nursing student population. BMC Psychiatry 2017; 17(1): 289.
[http://dx.doi.org/10.1186/s12888-017-1447-3] [PMID: 28784095]
[93]
Adam D. Mental health: On the spectrum. Nature 2013; 496(7446): 416-8.
[http://dx.doi.org/10.1038/496416a] [PMID: 23619674]

Rights & Permissions Print Cite
Article Metrics
26
© 2024 Bentham Science Publishers | Privacy Policy